Detection of relapse following allogeneic stem cell transplantation in AML:: NPM1-mutations precede the FLT3-LM/ITD and changes in chimerism

被引：0
|
作者：
Bacher, U. [1 ]
Badbaran, A. [1 ]
Fehse, B. [1 ]
Zabelina, T. [1 ]
Zander, A. R. [1 ]
Kroeger, N. [1 ]
机构：
[1] Univ Hamburg, Clin Stem Cell Transplant, Hamburg, Germany
来源：
ANNALS OF HEMATOLOGY | 2008年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [31] Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation
    Iannotta, R.
    Celentano, M.
    Marotta, S.
    Pedata, C. M.
    Riccardi, C.
    Migliaccio, I.
    Viola, A.
    Muggianu, S. M.
    Falco, C.
    Bovenzi, D.
    Ferrara, F.
    Picardi, A.
    LEUKEMIA RESEARCH REPORTS, 2022, 18
  • [32] Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations
    Heidrich, K.
    Thiede, C.
    Schaefer-Eckart, K.
    Schmitz, N.
    Aulitzky, W. E.
    Kraemer, A.
    Roesler, W.
    Haenel, M.
    Einsele, H.
    Baldus, C. D.
    Trappe, R. U.
    Stoelzel, F.
    Middeke, J. M.
    Roellig, C.
    Taube, F.
    Kramer, M.
    Serve, H.
    Berdel, W. E.
    Ehninger, G.
    Bornhaeuser, M.
    Schetelig, J.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2793 - 2798
  • [33] Emberger Syndrome with Concomitant GATA2, NPM1 and FLT3-ITD Mutations in Remission after Allogeneic Stem Cell Transplant
    Saste, Abhijit Balkrishna
    Jiang, Feng
    Arias-Stella, Javier, III
    Gamalski, Steven
    Peres, Edward
    Janakiraman, Nalini
    Farhan, Shatha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S208 - S209
  • [34] NPM1 mutations are valid minimal residual disease parameters following allogeneic stem cell transplantation: A study on 116 AML patients
    Bacher, Ulrike
    Badbaran, Anita
    Zander, Axel R.
    Fehse, Boris
    Kroger, Nicolaus
    BLOOD, 2007, 110 (11) : 493A - 494A
  • [35] Long term sorafenib response for extramedullary FLT3+AML relapse after allogeneic stem cell transplantation
    Sola, Elena
    Aguado, Beatriz
    Lopez-Pereira, Patricia
    Cornago, Javier
    Figuera, Angela
    Alegre, Adrian
    BONE MARROW TRANSPLANTATION, 2019, 54 : 522 - 523
  • [36] Sustained remission with Sorafenib treatment for extramedullary FLT3+-AML relapse after allogeneic stem cell transplantation
    Aguado, B.
    Jimenez-Barral, E.
    Arriero, A. V.
    Cornago, J.
    Figuera, A.
    Alegre, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S408 - S409
  • [37] The Impact of DNMT3A/FLT3-ITD/NPM1 on Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
    Su, Long
    TURKISH JOURNAL OF HEMATOLOGY, 2019, 36 (01) : 64 - 64
  • [38] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey
    Viswabandya, Auro
    Kim, Dennis
    Thyagu, Santhosh
    Messner, Hans
    Michelis, Fotios
    BONE MARROW TRANSPLANTATION, 2018, 53 : 169 - 170
  • [39] Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML
    Pasic, Ivan
    Da'na, Waleed
    Lam, Wilson
    Law, Arjun
    Lipton, Jeffrey H.
    Viswabandya, Auro
    Kim, Dennis D.
    Thyagu, Santhosh
    Messner, Hans A.
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (04) : 368 - 374
  • [40] Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation
    Braune, Jan
    Rieger, Kathrin
    Blau, Olga
    Keller, Ulrich
    Bullinger, Lars
    Kroenke, Jan
    CASE REPORTS IN HEMATOLOGY, 2022, 2022
12345